Senior Director, Health Outcome ResearchFerring Pharmaceuticalsparsippany, New Jersey, United States
Disclosure(s): Ferring Pharmaceuticals, Inc.: Employee
321 - Characteristics and Real-world Outcomes of Patients Administered with Fecal Microbiota, live-jslm for the Prevention of Recurrent Clostridioides difficile Infection (rCDI)
Friday, October 18, 202412:40 PM – 12:45 PM US PT